AI
ATRC icon

Acuitas Investments’s AtriCure ATRC Stock Holding History

Acuitas Investments’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,916
Closed -$846K – 69
2021
Q1 		$846K Sell
12,916
-1,950
-13% -$120K 0.49% 68
2020
Q4 		$828K Sell
14,866
-31,487
-68% -$1.36M 0.54% 64
2020
Q3 		$1.85M Sell
46,353
-14,422
-24% -$612K 1.3% 40
2020
Q2 		$2.73M Buy
+60,775
New +$2.65M 3.43% 9

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Acuitas Investments's ATRC Position: Q2 2021 in Review

Acuitas Investments sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 12,916 shares — an estimated $846K sold.

Acuitas Investments first reported a position in ATRC in Q2 2020 and held it in 4 quarters. The position peaked at $2.73M in Q2 2020. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

  • Acuitas Investments reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
  • Acuitas Investments sold 12,916 AtriCure shares in Q2 2021, an estimated $846K.
  • Acuitas Investments first reported a position in AtriCure in Q2 2020 and held it in 4 quarters.
  • Acuitas Investments's AtriCure position peaked at $2.73M in Q2 2020.
  • 212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Acuitas Investments's 13F filing for Q2 2021, filed 2 Aug 2021.